$306 Million is the total value of Tri Locum Partners LP's 31 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 97.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | Buy | WALGREENS BOOTS ALLIANCE INCcall | $52,610,000 | +24.5% | 1,000,000 | +29.9% | 17.22% | +64.3% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $42,241,000 | +38.0% | 75,627 | +16.9% | 13.82% | +82.1% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $24,137,000 | -10.6% | 257,764 | -12.2% | 7.90% | +18.0% |
| MDT | Sell | MEDTRONIC PLC | $22,924,000 | -19.0% | 184,680 | -22.9% | 7.50% | +6.9% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $22,395,000 | +2.0% | 425,671 | +6.5% | 7.33% | +34.6% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $15,876,000 | -12.5% | 89,370 | -19.0% | 5.20% | +15.5% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $15,333,000 | +130.3% | 341,650 | +32.9% | 5.02% | +203.9% |
| JNJ | Sell | JOHNSON & JOHNSON | $14,101,000 | -49.1% | 85,596 | -49.2% | 4.62% | -32.9% |
| CI | New | CIGNA CORP NEW | $12,019,000 | – | 50,699 | +100.0% | 3.93% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $9,268,000 | – | 818,025 | +100.0% | 3.03% | – |
| PFE | New | PFIZER INC | $7,937,000 | – | 202,692 | +100.0% | 2.60% | – |
| EOLS | Buy | EVOLUS INC | $6,285,000 | +496.9% | 496,826 | +513.2% | 2.06% | +688.1% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $6,155,000 | – | 150,783 | +100.0% | 2.02% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $5,862,000 | +44.7% | 175,305 | -10.9% | 1.92% | +90.9% |
| HUM | Sell | HUMANA INC | $5,005,000 | -66.6% | 11,305 | -68.3% | 1.64% | -55.9% |
| EW | New | EDWARDS LIFESCIENCES CORP | $4,999,000 | – | 48,267 | +100.0% | 1.64% | – |
| ENDP | New | ENDO INTL PLCcall | $4,905,000 | – | 1,048,100 | +100.0% | 1.60% | – |
| FLGT | New | FULGENT GENETICS INCcall | $4,612,000 | – | 50,000 | +100.0% | 1.51% | – |
| MRNA | New | MODERNA INC | $4,510,000 | – | 19,193 | +100.0% | 1.48% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $4,414,000 | – | 445,900 | +100.0% | 1.44% | – |
| EGRX | New | EAGLE PHARMACEUTICALS INC | $4,063,000 | – | 94,922 | +100.0% | 1.33% | – |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $3,974,000 | – | 1,253,729 | +100.0% | 1.30% | – |
| LSAQ | Sell | LIFESCI ACQUISITION II CORP | $2,699,000 | -11.3% | 269,872 | -10.0% | 0.88% | +17.1% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,112,000 | +45.8% | 313,795 | +95.8% | 0.69% | +92.5% |
| ARGX | New | ARGENX SEsponsored adr | $1,929,000 | – | 6,408 | +100.0% | 0.63% | – |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $1,855,000 | -11.1% | 313,331 | +6.8% | 0.61% | +17.4% |
| FEMY | New | FEMASYS INC | $1,531,000 | – | 188,753 | +100.0% | 0.50% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $1,168,000 | -20.0% | 375,520 | -1.2% | 0.38% | +5.5% |
| ISEE | New | IVERIC BIO INC | $611,000 | – | 96,820 | +100.0% | 0.20% | – |
| AMRX | Exit | AMNEAL PHARMACEUTICALS INC | $0 | – | -139,470 | -100.0% | -0.23% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -68,472 | -100.0% | -0.30% | – |
| IMTX | Exit | IMMATICS N.V | $0 | – | -121,743 | -100.0% | -0.34% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INCput | $0 | – | -140,000 | -100.0% | -0.62% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INCcall | $0 | – | -140,000 | -100.0% | -0.62% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -142,911 | -100.0% | -0.86% | – |
| CASI | Exit | CASI PHARMACEUTICALS INC | $0 | – | -1,500,000 | -100.0% | -0.89% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -1,210,863 | -100.0% | -0.97% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -180,261 | -100.0% | -1.00% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -164,199 | -100.0% | -1.03% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -578,930 | -100.0% | -1.54% | – | |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -321,101 | -100.0% | -1.64% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -148,620 | -100.0% | -1.78% | – |
| NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -6,644,337 | -100.0% | -1.93% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -48,299 | -100.0% | -2.24% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -333,482 | -100.0% | -3.61% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -390,992 | -100.0% | -6.12% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -314,136 | -100.0% | -6.57% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCput | $0 | – | -770,000 | -100.0% | -10.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.